elizabeth mittendorf, md, phd, on the implications of the impassion-130 and impassion-131 trials
Published 4 years ago • 56 plays • Length 2:19Download video MP4
Download video MP3
Similar videos
-
4:42
elizabeth mittendorf, md, phd, considers key takeaways from the impassion-131 presented at esmo 2020
-
3:54
elizabeth mittendorf, md, phd, discusses the outcomes of the impassion-031 study
-
0:57
dr. mittendorf on the impact of pertuzumab in her2 breast cancer
-
1:12
dr. mittendorf discusses immunotherapy efforts in breast cancer
-
1:27
dr. elizabeth mittendorf on clinical trials exploring a new breast cancer vaccine
-
2:01
breast cancer research at esmo 20: elizabeth ann mittendorf, md, phd
-
23:38
ask the expert: triple negative breast cancer
-
5:05
anti-her2 mechanisms of approved her2 inhibitors
-
22:26
triple-negative breast cancer: what's new in treatment and research at mbc patient forum 2019
-
4:27
the impassion130 study in metastatic tnbc
-
1:24
dr. mittendorf on nelipepimut-s plus gm-csf in breast cancer
-
8:42
chemoimmunotherapy in tnbc: the impassion130 trial
-
2:41
dr. mittendorf on peptide vaccines for the treatment of breast cancer
-
2:46
dr. mittendorf discusses cyclin e as a target in breast cancer
-
4:25
primary analysis of ae37 vaccine in breast cancer - dr. elizabeth mittendorf asco 2014
-
4:56
results from the impassion 130 trial treating metastatic breast cancer
-
3:50
breast cancer at esmo 2020: impassion131, solar-1, pallas and more
-
6:54
impassion130 trial data on pd-l1 tumors in tnbc
-
2:30
impassion130: immunotherapy for tnbc
-
1:16
the impassion130 trial in metastatic triple-negative breast cancer
-
6:56
impassion130 trial data on pd-l1 tumors in tnbc
-
1:44
debu tripathy, md, elaborates on outcomes from the impassion130 trial